You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

22 January 2021

Brazil provides more evidence on link between dolutegravir and birth defects

Review initially finds dolutegravir has no links to birth defects then revises its findings to report a ‘slightly higher’ – but minimal – incidence after two cases emerge

05 January 2021

Make ‘U=U’ discussions a standard part of HIV care, researchers urge

Global survey finds a high proportion of people living with HIV know that ‘Undetectable = Untransmittable’ – and are more likely to be healthy compared to those who are unaware.

09 December 2020

Voucher scheme to encourage young South African women to take PrEP has modest impact

Trial reports a 15% difference in high PrEP adherence among participants who received vouchers compared to those who didn’t – but this fell significantly after the vouchers stopped.

01 December 2020

3 steps to a happy and healthy sex life – World AIDS Day 2020

Sexual health is about so much more than infection prevention – it’s about being happy with yourself and in your sex life. Help us to spread the word that everyone has a right to pleasurable and safer sex!

22 October 2020

Urgent need to address mental health among women who sell sex

Women who sell sex are experiencing high levels of mental health issues, reveals a groundbreaking evidence review.

07 October 2020

Should men who buy sex be considered a key population?

The first evidence review to focus on men who buy sex – rather than women who sell it – finds a strong association between purchasing sex and HIV.

31 July 2020

‘Significant step’ for HIV prevention as vaginal ring gets green light from the European Medicines Agency

Ring containing the antiretroviral drug dapivirine could be available in Africa as early as 2021 after it was found to reduce women’s HIV risk by 30 to 50%.

23 July 2020

Injectable PrEP – an exciting tool, but no silver bullet for adherence

We talk to Giffin Daughtridge, CEO of medical diagnostics company, UrSure, about treatment adherence and the impact of long-acting cabotegravir as injectable PrEP.

07 July 2020

Africa hailed for HIV success, but unequal progress means targets will be missed

The 23rd International AIDS Conference (AIDS 2020 Virtual) kicked-off with a clear message from UNAIDS to accelerate efforts to end AIDS and not be derailed by COVID-19.

23 June 2020

Hundreds of young Nigerians crowdsource ideas to improve HIV self-testing

Peer distribution, youth branding and social media campaigns emerge as top ideas in crowdsourcing contest to improve HIV self-testing among young people.